MassDevice Q&A
Q&A Features
02/15/2012
by
MassDevice staff
ConforMIS CEO Philipp Lang talks to MassDevice.com on how the custom orthopedic implant maker plans to spend its most recent $90 million funding round and on what makes his company stand out in the crowded orthopedics arena.
Philipp Lang has ConforMIS looking to get a leg up on the knee replacement industry.
Last week, the Burlington, Mass.-based orthopedic implant maker said it raised $89 million in a Series E round from several investors, bringing the total nut raised by ConforMIS over the last 3 years to more than $140 million – a somewhat remarkable amount,...
02/07/2012
by
Arezu Sarvestani
Soteira CEO Larry Jasinski talks to MassDevice about overcoming the odds with spinal fusion devices and managing a 510(k) win even after the FDA switched things up mid-stream.
Click to play
Soteira CEO Larry Jasinski is no stranger...
01/10/2012
by
Brad Perriello
Medtronic CEO Omar Ishrak tells MassDevice.com about how he screens potential acquisitions, his plan to re-shape the company and handling the controversy over the Infuse spine treatment.
Just a few days into his tenure as CEO of Medtronic (NYSE:MDT), Omar Ishrak was confronted with a major crisis: The Spine Journal devoted its entire June issue to to exposing problems with growth proteins, including a repudiation of some of the research surrounding Infuse.
The...
12/26/2011
by
Brian Johnson
MassDevice goes one-on-one with the senior VP of Abbott Medical Optics and the chairman of AdvaMed about the state of the device industry.
You don't get more dialed-in to the device industry than James Mazzo, and you definitely don't get busier.
In addition to his duties as senior VP of Abbott Medical Optics Inc., an ophthalmic company he spun out of Allergan (NYSE:AGN) and then sold to health care giant Abbott (NYSE:ABT) in 2009, Mazzo has...
12/14/2011
by
Arezu Sarvestani
Alfred Mann Foundation CEO David Hankin tells MassDevice how to make an artificial nervous system using microstimulators that communicate wirelessly through the body.
Click to play
David Hankin became...
12/05/2011
by
Brad Perriello
The newly minted CEO of AngioDynamics on his unique family business background, the importance of good neighbors and the company's path along the mergers & acquisitions trail.
AngioDynamics (NSDQ:ANGO) CEO Joe DeVivo's deep roots in the medical device industry are common knowledge. The former CEO of RITA Medical Systems (acquired, as it happens, by AngioDynamics in 2006) spent four years at the helm of Smith & Nephew's (NYSE:...
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
